Chinook Therapeutics Inc.
210-887 Great Northern Way
Member Sector: Biopharmaceuticals
Chinook Therapeutics is a drug discovery company developing precision medicines for kidney disease. Kidney disease is an underserved therapeutic area accounting for over $100B in annual costs, largely due to a lack of treatments to prevent progression to end stage renal disease. Chinook is building a pipeline of drugs for well-characterized kidney diseases enabled by input from leading academic groups and a discovery platform providing unique insights into kidney biology. Our lead program targets a severe, rare disease with validated biology and a rapid development pathway.
Chinook is anchored by our highly experienced small molecule drug discovery team who were former leaders at Merck Frosst and Inception Sciences Canada